RxDoctor Payments DataLook up a doctor →

Barbara Bowers, NP

Adult Health · Indianapolis, INNPI 1407851033

Payments from drug & device makers

$6,987in general payments, 2019–2025

Across 351 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • UCB, Inc.$579
  • Biogen$559
  • Lilly USA, LLC$426
  • Neurocrine Biosciences, Inc.$365
  • Jazz Pharmaceuticals Inc.$362
  • plus $3K from 42 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)79$1,219
UCB, Inc.22$579
Biogen22$559
Lilly USA, LLC26$426
Neurocrine Biosciences, Inc.22$365
Jazz Pharmaceuticals Inc.13$362
SK Life Science, Inc.11$292
Catalyst Pharmaceuticals, Inc.9$273
Amgen(2 entities)13$214
Genentech USA, Inc.10$193
Alnylam Pharmaceuticals Inc.8$190
TG Therapeutics, Inc.7$151
Harmony Biosciences LLC4$147
Argenx US, Inc.8$147
Pfizer7$134
Acadia Pharmaceuticals Inc8$124
Lundbeck LLC5$111
Eisai Inc.5$106
AstraZeneca5$95
Mallinckrodt Hospital Products Inc.4$94
Banner Life Sciences, LLC4$92
Scilex Pharmaceuticals Inc.5$82
Sumitomo Pharma America, Inc.3$75
Teva Pharmaceuticals USA, Inc.5$71
Johnson & Johnson3$65
Amneal Pharmaceuticals LLC3$62
Tanabe Pharma America, Inc.3$59
Sanofi3$58
Livanova USA, Inc.3$58
CSL Behring3$56
Springworks Therapeutics, Inc.2$54
Takeda Pharmaceuticals U.S.A., Inc.3$53
EMD Serono, Inc.3$53
Biohaven Pharmaceutical Holding Company Ltd.2$48
Idorsia Pharmaceuticals US Inc3$43
Abbott2$40
Neurelis, Inc.2$31
Aquestive Therapeutics, Inc.1$29
Sanofi-aventis U.S. LLC1$23
Nevro Corp.1$21
Novartis1$21
Acorda Therapeutics, Inc1$20
Avadel CNS Pharmaceuticals, LLC1$20
Upsher-smith Laboratories LLC1$18
Merck1$16
Aucta Pharmaceuticals, Inc.1$14
Avion Pharmaceuticals1$12
Aprecia Pharmaceuticals, LLC1$12

How this compares

$6,987 in reported general payments places this provider in the 90th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana →

Medicare billing

Part B allowed, 2024
$9,793
Medicare patients
75
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →